Timor-Leste made history when it was validated by @who for eliminating lymphatic filariasis (LF) as a public health problem, becoming the first country to achieve this using a "triple therapy" treatment strategy.

Highlighted in our latest annual report, this landmark milestone safeguards 1.4 million people from permanent disability. The achievement was driven by strong leadership and dedication from the Ministry of Health, local health workers, and with donated medicines from @merck, @gsk, and Eisai. The Task Force’s @Mectizan Donation Program manages Mectizan donations and coordinates delivery of GSK’s albendazole. Timor-Leste’s success is already paving the way for other nations fighting LF. Read the full story in our annual report linked in our bio.